PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

CHMP recommend approval for Roche’s COVID-19 therapy

According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients. Roche has announced the Comm...
Continue Reading →
News

UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response

Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries. A British study mixing COVID-19 vaccin...
Continue Reading →
News

Next virus could be more lethal than COVID-19, warns Oxford vaccine creator

With the emergence of the new Omicron variant bringing into question the effectiveness of current vaccines, scientists caution that viruses will continue to evolve. ...
Continue Reading →
News

NICE recommends Tagrisso for patients with early-stage lung cancer

Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as...
Continue Reading →
News

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. ...
Continue Reading →
News

GSK aim for HIV cure by 2030

Following its recent approval of an injectable HIV-1 treatment from the National Institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hope...
Continue Reading →
News

Total UK cases of Omicron rise to nine

An additional six cases of the Omicron variant have now been detected in Scotland, bringing the UK total so far to nine. As of 26 November 2021, two people in the...
Continue Reading →
News

Late cancer diagnoses rise as NHS struggles with COVID-19

Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-1...
Continue Reading →
News

Nemera reinforces its value proposition with a refreshing visual identity

More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the...
Continue Reading →
News

New depression treatment options from NICE

The National Institute for Health and Care Excellence (NICE) has created a new menu of treatment options for those living with depression. It is the first guide...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026